# Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans

> **NCT07331194** · PHASE1 · COMPLETED · sponsor: **Hutchmed** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HMPL-523 Acetate Tablets (Test Formulation)
- **DRUG:** HMPL-523 Acetate Tablets (Reference Formulation)

## Key facts

- **NCT ID:** NCT07331194
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-28
- **Primary completion:** 2025-11-28
- **Final completion:** 2026-02-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07331194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07331194, "Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07331194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*